Sinovac to Present at Piper Jaffray Health Care Conference

Share Name	Share Symbol	Market	Type
Sinovac Biotech Ltd	NASDAQ:SVA	NASDAQ	Common Stock

Share Name

Share Symbol

Market

Type

Sinovac Biotech Ltd

NASDAQ:SVA

NASDAQ

Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	6.47	5.09	123.45				0	00:00:00

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

6.47

5.09

123.45

00:00:00

Sinovac to Present at Piper Jaffray Health Care Conference

24/11/2009 1:00pm

PR Newswire (US)

Sinovac Biotech (NASDAQ:SVA)
Historical Stock Chart

From Mar 2020 to Mar 2025

Click Here for more Sinovac Biotech Charts.

BEIJING, Nov. 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 8 a.m. Eastern time. The conference is scheduled for December 1-2 at the New York Palace in New York, NY. A live webcast of the presentation will be available online on the Investor Relations home page of Sinovac's corporate Web site at http://www.sinovac.com/ . About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines. For more information, please contact: Helen G. Yang Sinovac Biotech Ltd. Tel: +86-10-8289-0088 x9871 Fax: +86-10-6296-6910 Email: Investors: Amy Glynn/Stephanie Carrington The Ruth Group Tel: +1-646-536-7023/7017 Email: Media: Janine McCargo The Ruth Group Tel: +1-646-536-7033 Email: DATASOURCE: Sinovac Biotech Ltd. CONTACT: Helen G. Yang of Sinovac Biotech Ltd., +86-10-8289-0088 x9871, fax +86-10-6296-6910, ; or Investors, Amy Glynn, or Stephanie Carrington, , both of The Ruth Group, +1-646-536-7023/7017; or Media, Janine McCargo, The Ruth Group, +1-646-536-7033, Web site: http://www.sinovac.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SVA Sinovac Biotech Ltd